Changes in ejection fraction (EF) following sequential anthracycline and trastuzumab in patients with HER2+ early breast cancer (EBC) – is there a need for two echocardiograms pre-trastuzumab?
Citation
Changes in ejection fraction (EF) following sequential anthracycline and trastuzumab in patients with HER2+ early breast cancer (EBC) – is there a need for two echocardiograms pre-trastuzumab? 2017, 29 (6):e99 Clinical OncologyJournal
Clinical OncologyDOI
10.1016/j.clon.2017.01.020Additional Links
http://linkinghub.elsevier.com/retrieve/pii/S0936655517300468Type
Meetings and ProceedingsLanguage
enISSN
09366555ae974a485f413a2113503eed53cd6c53
10.1016/j.clon.2017.01.020